Eisner Mark reported ZURA

Source

Document

SEC Form 4

Publisher

U.S. Securities and Exchange Commission (EDGAR)

Document ID

0001834161-26-000008

Machine-readable

Structured copy

Timestamps

Event (reported)

Jun 17, 2026

Published

Jun 22, 2026

Ingested by INSIDER

Nov 5, 03:51 UTC

Last re-read

Nov 5, 03:51 UTC

Extracted facts

Filer

Eisner Mark

Role

Director

Transaction

Grant or awardAs filed: “A”

Asset

Zura Bio Ltd — Share Option (Right to Buy)

Ticker

ZURA

Shares

51.0K

Price per share

$0

Execution date (reported)

Jun 17, 2026

Owned after transaction

51.0K shares

Days from execution to publication

5

What this establishes

Eisner Mark filed this Form 4 reporting a grant or award of ZURA on Jun 17, 2026. It became public on Jun 22, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.

Extraction

Method

Form 4 XML

Confidence

1.00

Director

Eisner Markcik:0001834161

Issuer

Zura Bio Ltdcik:0001855644

Revision history · 0

No field has changed since this record was first ingested.